Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon (2011)

  • Authors:
  • USP affiliated authors: BONFA, ELOISA SILVA DUTRA DE OLIVEIRA - FM
  • USP Schools: FM
  • DOI: 10.1007/s10067-010-1432-4
  • Subjects: INFLAMAÇÃO; VASCULITE (IMUNOLOGIA); LÚPUS ERITEMATOSO SISTÊMICO (IMUNOLOGIA); PROTEÍNAS; MANIFESTAÇÕES CUTÂNEAS
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s10067-010-1432-4 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed
    Versões disponíveis em Acesso Aberto do: 10.1007/s10067-010-1432-4 (Fonte: Unpaywall API)

    Título do periódico: Clinical Rheumatology

    ISSN: 0770-3198,1434-9949



      Não possui versão em Acesso aberto
    Informações sobre o Citescore
  • Título: Clinical Rheumatology

    ISSN: 0770-3198

    Citescore - 2017: 2.04

    SJR - 2017: 0.93

    SNIP - 2017: 0.877


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2210075-10BCBIB
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      SHINJO, Samuel Katsuyuki; BONFÁ, Eloísa. Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon. Clinical rheumatology, Brussels, n. 2, p. 173-177, 2011. Disponível em: < "Clicar" sobre o botão para acesso ao texto completo > DOI: 10.1007/s10067-010-1432-4.
    • APA

      Shinjo, S. K., & Bonfá, E. (2011). Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon. Clinical rheumatology, ( 2), 173-177. doi:10.1007/s10067-010-1432-4
    • NLM

      Shinjo SK, Bonfá E. Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon [Internet]. Clinical rheumatology. 2011 ;( 2): 173-177.Available from: "Clicar" sobre o botão para acesso ao texto completo
    • Vancouver

      Shinjo SK, Bonfá E. Cutaneous vasculitis in systemic lupus erythematosus: association with anti-ribosomal P protein antibody and Raynaud phenomenon [Internet]. Clinical rheumatology. 2011 ;( 2): 173-177.Available from: "Clicar" sobre o botão para acesso ao texto completo

    Referências citadas na obra
    Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190:104–111
    Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291–437
    Gilliam JN, Sontheimer RD (1981) Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 4:471–475
    Ansari A, Larson PH, Bates HD (1986) Vascular manifestations of systemic lupus erythematosus. Angiology 37:423–432
    Caproni M, Chiarugi A, Bernacchi E, Fabbri P (1998) Severe cutaneous ulcerations in a black woman with systemic lupus erythematosus. Clin Exp Rheumatol 16:508
    Weinstein C, Miller MH, Axtens R et al (1987) Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust NZ J Med 17:501–506
    D’Cruz D (1998) Vasculitis in systemic lupus erythematosus. Lupus 7:270–274
    Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D (1997) Vasculitis in systemic lupus erythematosus. Lupus 6:235–242
    O’Loughlin S, Schroeter AL, Jordon RE (1978) Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol 114:879–883
    Provost TT, Zone JJ, Synkowski D, Maddison PJ, Reichlin M (1980) Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria like lesions. Correlation with clinical and serological abnormalities. J Invest Dermatol 75:495–499
    Callen JP, Kingman J (1983) Cutaneous vasculitis in systemic lupus erythematosus. A poor prognostic indicator. Cutis 32:433–436
    Rothfield N, Sontheimer RD, Bernstein M (2006) Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol 24:348–362
    Vitali C, Bencivelli W, Isenberg DA, the European Consensus Study Group for Disease Activity in SLE et al (1992) Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. Clin Exp Rheumatol 10:527–539
    López-Longo FJ, González Fernández CM, Rodríguez Mahou M et al (1997) Clinical expression of systemic lupus erythematosus with anti-U1-RNP and anti-Sm antibodies. Rev Clin Esp 197:329–335
    Ramos-Casals M, Nardi N, Lagrutta M et al (2006) Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85:95–104
    Beaufils M, Kouki F, Mignon F, Camus JP, Morel-Maroger L, Richet G (1983) Clinical significance of anti-Sm antibodies in systemic lupus erythematosus. Am J Med 74:201–205
    Gonzalez-Gay MA, Garcia-Porrua C, Pujol RM (2005) Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 17:56–61
    Fukuda MV, Lo SC, de Almeida CS, Shinjo SK (2009) Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus. Clin Rheumatol 28:301–304
    Van Dam A, Nossent H, de Jong J et al (1991) Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study. J Rheumatol 18:1026–1034
    Tzioufas AG, Tzortzakis NG, Panou-Pomonis E et al (2000) The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease. Ann Rheum Dis 59:99–104
    Caponi L, Pegoraro S, Di Bartolo V et al (1995) Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. J Immunol Methods 179:193–202
    Gerli R, Caponi L, Tincani A et al (2002) Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. Rheumatology 41:1357–1366
    Briani C, Lucchetta M, Ghirardello A et al (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32:79–84
    Bonfá E, Golombek SJ, Kaufman LD (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271
    Senecal JL, Raymond Y (2004) The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease? J Rheumatol 31:2093–2098
    Ebert T, Chapman J, Shoenfeld Y (2005) Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality? Lupus 14:571–575
    Schneebaum AB, Singleton JD, West SG (1991) Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90:54–62
    Isshi K, Hirohata S (1996) Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 39:1483–1490
    Massardo L, Burgos P, Martinez ME (2002) Antiribosomal P protein antibodies in Chilean SLE patients: no association with renal disease. Lupus 11:379–383
    Reichlin M (2006) Autoantibodies to the ribosomal P proteins in systemic lupus erythematosus. Clin Exp Med 6:49–52
    do Nascimento AP, Viana Vdos S, Testagrossa Lde A et al (2006) Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis. Arthritis Rheum 54:1568–1572
    Chindalore V, Neas B, Reichlin M (1998) The association between anti-ribosomal P antibodies and active nephritis in systemic lupus erythematosus. Clin Immunol Immunopathol 87:292–296
    Martin AL, Reichlin M (1996) Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE. Lupus 5:22–29
    Koren E, Schnitz RM (1993) Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus. Arthritis Rheum 36:1325–1328
    Hulsey M, Goldstein R, Scully L et al (1995) Anti-ribosomal P antibodies in systemic lupus erythematosus: a case–control study correlating hepatic and renal disease. Clin Immunol Immunopathol 74:252–256
    Arnett FC, Reichlin M (1995) Lupus hepatitis: an underrecognized disease feature associated with autoantibodies to ribosomal P. Am J Med 99:465–472
    Ghirardello A, Doria A, Zampieri S et al (2000) Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies. Ann Rheum Dis 59:9759–9781
    Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
    Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640
    Tan EM, Peebles C (1980) Quantitation of antibodies to Sm antigen and nuclear ribonucleoprotein by hemagglutination. In: Rose NR, Friedman H (eds) Manual of clinical immunology, 2nd edn. American Society of Microbiology, Washington, pp 866–870
    Kurata N, Tan EM (1976) Identification of antibodies to nuclear acidic antigens by counterimmunoelectrophoresis. Arthritis Rheum 19:574–580
    Elkon KB, Culhane L (1984) Partial immunochemical characterization of the Ro and La proteins using antibodies from patients with the sicca syndrome and lupus erythematosus. J Immunol 132:2350–2356
    Gharavi AE, Harris EN, Asherson RA, Hughes GR (1987) Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 46:1–6
    Bonfá E, Golombek SJ, Kaufman LD et al (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271
    Brandt JT, Triplett DA, Alving B, Scharrer I (1995) Criteria for diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 74:1185–1190
    Gomes C, de Carvalho JF, Borba EF, Borges CTL, Vendramini MB, Bueno C, Costa LP, Bonfá E (2009) Digital vasculitis in systemic lupus erythematosus: a minor manifestation of disease activity? Lupus 18:990–993
    Cardininali C, Caproni M, Bernacchi E, Amato L, Fabbri P (2000) The spectrum of cutaneous manifestations in lupus erythematosus—the Italian experience. Lupus 9:417–423
    Ramos-Casals M, Anaya JM, García-Carrasco M, Rosas J, Bové A, Claver G, Diaz LA, Herrero C, Font J (2004) Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 83:96–106
    Kasparian A, Floros A, Gialafos E et al (2007) Reynaud’s phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 16:505–508
    Haddouk S, Marzouk S, Jallouli M, Fourati H, Frigui M, Hmida YB, Koubaa F, Sellami W, Baklouti S, Hachicha J, Bahloul Z, Masmoudi H (2009) Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus. Rheumatol (Oxford) 48:953–957